PCSK9 Hapten Multicopy Displayed onto Carrier Protein Nanoparticle: An Antiatherosclerosis Vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PCSK9 Hapten Multicopy Displayed onto Carrier Protein Nanoparticle: An Antiatherosclerosis Vaccine

Published:2019-07-29 Issue:9 Volume:5 Page:4263-4271
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

You Shasha¹,Guo Xiaoyu¹,Xue Xiaomei¹,Li Yongyong²^ORCID,Dong Haiqing²,Ji Haiying¹,Hong Ting¹,Wei Yazhong¹,Shi Xueyin¹,He Bin¹^ORCID

Affiliation:

1. Department of Anesthesiology and SICU, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

2. Institute for Biomedical Engineering & Nano Science, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200092, China

Funder

Shanghai Jiao Tong University

Shanghai Hospital Development Center

Shanghai Municipal Education Commission

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.9b00434

Reference36 articles.

1. Heart Disease and Stroke Statistics—2015 Update

2. What to expect in 2015

3. In Pursuit of an Atherosclerosis Vaccine

4. Molecular basis for LDL receptor recognition by PCSK9

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia;Cell Reports Medicine;2024-06

2. Efferocytosis-inspired nanodrug treats sepsis by alleviating inflammation and secondary immunosuppression;Biomedical Materials;2023-08-22

3. The Immunogenic Potential of PCSK9 Peptide Vaccine in Mice;Current Medicinal Chemistry;2023-08

4. Research progress on the therapeutic effects of nanoparticles loaded with drugs against atherosclerosis;Cardiovascular Drugs and Therapy;2023-05-13

5. Preclinical toxicity assessment of a peptide-based antiPCSK9 vaccine in healthy mice;Biomedicine & Pharmacotherapy;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3